Biodefense Market value to surpass $19 Billion by 2024: Global Market Insights, Inc.

U.S. biodefense market is projected to register 6%+ CAGR from 2019 to 2025 as government initiates several programs focused on preparedness and prevention intentional or accidental releases of biological material will boost the industry demand.

Sellbyville, Delaware, Jan. 30, 2019 (GLOBE NEWSWIRE) --

Canada biodefense market was valued at USD 349.3 million in 2017 and is expected to have considerable revenue size during the forecast period. Rising government initiatives and funds for taking preventive measures against the bioterrorism attacks will drive the industry growth. Moreover, growing availability of superior quality vaccines and technologically advanced bio-defense devices will trigger the industry growth.

Global Biodefense Market size is set to exceed USD 19 billion by 2024; according to a new research report by Global Market Insights, Inc. Technological advancements in biotechnology sector will positively influence the biodefense market growth. Advancements in biotechnology includes developments in detectors that are utilized in assessing the threat against deliberate release of viruses and microbes. This scenario proves beneficial for the biodefense market growth as it surges the demand for vaccines and biothreat identifying agents such as assays as well as reagents in case of any bioterrorism attack.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/714

Government in developed countries is highly aware regarding the impact of bioterrorism attacks on economy that should positively impacts biodefense market growth. Several strategies are implemented including stocking the vaccines and production of bio-threat detection devices to secure the population against bioterrorism attacks. Currently, government in developing countries is also indulging in activities that assure safety against any intentional virus attack. For instance, economies such as India are more susceptible to agricultural bioterrorism and hence, government is undertaking several initiatives to protect the nation as majority of the population relies on agriculture as it is their main occupation. However, low R&D funding by government in developing and underdeveloped economies will hamper the industry growth in forthcoming years.

Vaccines segment was valued at USD 7.8 billion in 2017. Rising government initiatives will elevate the demand for superior quality vaccines that are stocked to fight infections caused due to sudden attack of viruses. Recently developed vaccines are highly efficient and create strong immunological response that helps in combating infection creating immunogenic memory. Growing preference for broad spectrum vaccines capable of inducing strong immunogenic response against microbial and viral infections will propel the segmental growth during the forecast period.

Browse key industry insights spread across 115 pages with 44 market data tables & 06 figures & charts from the report, “Biodefense Market” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/biodefense-market

UK biodefense market will witness 6.3% CAGR over the forecast timeframe. Increasing technological advancements in biotechnology sector will boost the production of vaccines surging the segmental growth in upcoming years. Extensive research and development activities have brought innovations in the bio-threat detection devices that will augment UK biodefense market in near future.

Key industry players in biodefense market includes Altimmune, AISense, Emergent BioSolutions, Dynavax Technologies, SIGA Technologies, Elusys Therapeutics, Ichor Medical Systems, DynPort Vaccine Company, Cleveland BioLabs, Bavarian Nordic, Achaogen, Nanotherapeutics, Alnylam Pharmaceuticals, PathSensors and BBI Detection. These prominent players implement several strategic initiatives such as mergers and acquisitions to sustain the industry competition. Receiving FDA approvals for new products also enhances the revenue growth of the companies. For instance, in July 2018, SIGA Technologies received FDA approval for TPOXX that is utilized in the treatment of small pox. This will help the company to achieve sustainable profits as the product is approved and will be marketed to customers.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/714

Browse Related Reports:

  • Global Vaccines Market Size Forecast 2018 – 2024

Global Vaccines Market surpassed USD 32 billion in 2016 and is expected to witness more than 9% CAGR from 2017 to 2024 driven by rising prevalence of several infectious and non-infectious diseases globally coupled with increasing funding for vaccine development.

https://www.gminsights.com/industry-analysis/vaccines-market

  • Veterinary vaccines Market Size Outlook 2018 – 2024

Veterinary Vaccines Market size is projected to experience significant growth from 2018 to 2024. Rising burden of zoonotic diseases across the globe will drive veterinary vaccines market growth over the forecast timeline.       
https://www.gminsights.com/industry-analysis/veterinary-vaccines-market

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

CONTACT: Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://news-researchers.com/

Ads